PATENT CLAIM ANALYSIS

Application Number: 16061247
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["549", "285000"]

Abstract:
Disclosed is a configurational stereoisomer, named enantiomer E 3 , of flocoumafen, the enantiomer E 3  having, by chromatographic analysis of flocoumafen performed under particular conditions, a retention time t 3  having a value such that t 1 <t 2 <t 3 <t 4 ; t 1 , t 2  and t 4  representing the retention times of the configurational stereoisomers of flocoumafen different from the enantiomer E 3 , the analysis being performed at a temperature of 23.5° C.

Claim (Index 2):
Composition comprising a configurational stereoisomer, named enantiomer E 3 , of flocoumafen, with the exclusion of a racemic mixture of said enantiomer E 3  and of a configurational stereoisomer, named enantiomer E 2 , of flocoumafen;\n said enantiomer E 3  having, by chromatographic analysis of a flocoumafen composition comprising four configurational stereoisomers of flocoumafen performed under the conditions described below, a retention time t 3 ; said enantiomer E 2  having, by chromatographic analysis of a flocoumafen composition comprising four configurational stereoisomers of flocoumafen performed under these same conditions, a retention time t 2 ; t 3  and t 2  being values such that t 1 <t 2 <t 3 <t 4 ; t 1  and t 4  representing the retention times of each of the configurational stereoisomers of flocoumafen different from said enantiomer E 3  and from said enantiomer E 2 , said analysis being performed at a temperature of 23.5\u00b0 C. and under the following conditions: on a high-pressure liquid chromatography column of dimensions 150\u00d72 mm, and comprising a chiral stationary phase constituted of particles of tris(4-chloro-3-methylphenyl carbamate) cellulose, said particles having a mean size of 3 \u03bcm and having a mean pore size of 1000 \u212b; using, as liquid mobile phase, a mixture formed from acetonitrile (A) and water comprising 0.1% by volume of formic acid (B), with an A/B volume ratio of 92/8 and with a flow rate of the liquid mobile phase in the chromatography column of 0.25 mL/minute; by injection into the chromatography column of a volume of 1 \u03bcL of flocoumafen composition at a concentration of 1 \u03bcg of flocoumafen per millilitre of acetonitrile.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 94.0
- Lexical Diversity: 2.0
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16061115', '16061084', '15735677', '15318123', '15318195']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7624594655089066
- 35 USC 102 Novelty (BERT): 0.6221121940744561
- Combined Prediction Score: 0.7484247383654615
- Mean Citation Score: 420.160186
- Max Citation Score: 621.11487
- Similarity Product: 512.8043749554777

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test